| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +66.67% | -11.30% | -2.04% | -9.27% | -15.42% | — |
| 14d | 3 | +100.00% | -10.28% | -0.25% | -10.02% | -16.65% | — |
| 30d | 3 | +66.67% | -22.45% | +2.58% | -25.02% | -38.54% | — |
| 60d | 3 | +100.00% | -32.15% | +8.80% | -40.95% | -54.64% | — |
| 90d | 3 | +100.00% | -27.26% | +8.63% | -35.88% | -43.30% | — |
| 180d | 3(1 pending) | +100.00% | -55.73% | +16.33% | -72.06% | -72.06% | — |
| 1y | 3(1 pending) | +100.00% | -67.68% | +11.84% | -79.52% | -79.52% | — |
| 2y | 3(1 pending) | +100.00% | -85.70% | +4.35% | -90.05% | -90.05% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 17,786 | — | — | 17,786 | Jun 3, 2026 | Jun 5, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 605 | $36.80 | $22.3K | 4,237 | Mar 13, 2026 | Mar 17, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 13,489 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 10,034 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 144,000 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 16,562 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 131,372 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 12,500 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNAM AVIDITY BIOSCIENCES, INC. | SALE | 115,500 | — | — | 0 | Feb 27, 2026 | Feb 27, 2026 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,758 | $72.45 | $127.4K | 16,562 | Jan 21, 2026 | Jan 23, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 1,211 | — | — | 0 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 1,211 | — | — | 4,842 | Dec 31, 2025 | Jan 5, 2026 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALEGRANT Gift | 1,330 | — | — | 18,320 | Dec 19, 2025 | Dec 22, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 1,211 | — | — | 3,631 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 1,211 | — | — | 1,211 | Sep 30, 2025 | Oct 2, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 107,500 | $22.34 | $2.40M | 127,150 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 107,500 | — | — | 12,500 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 107,500 | $47.62 | $5.12M | 19,650 | Aug 6, 2025 | Aug 8, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 1,210 | — | — | 2,422 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 1,210 | — | — | 2,420 | Jun 30, 2025 | Jul 2, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,692 | — | — | 19,650 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,034 | — | — | 10,034 | Jun 10, 2025 | Jun 12, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 29,747 | — | — | 29,747 | Jun 3, 2025 | Jun 4, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 1,210 | — | — | 1,210 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 1,210 | — | — | 3,632 | Mar 31, 2025 | Apr 2, 2025 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 4,842 | — | — | 4,842 | Mar 19, 2025 | Mar 20, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,872 | $28.60 | $53.5K | 12,958 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 3,323 | — | — | 0 | Nov 19, 2024 | Nov 20, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 3,323 | $42.12 | $140.0K | 14,830 | Nov 19, 2024 | Nov 20, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 3,323 | $1.24 | $4.1K | 18,153 | Nov 19, 2024 | Nov 20, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 3,323 | Oct 21, 2024 | Oct 23, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Oct 21, 2024 | Oct 23, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $46.63 | $233.2K | 14,830 | Oct 21, 2024 | Oct 23, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $45.73 | $228.7K | 14,830 | Sep 19, 2024 | Sep 20, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 8,323 | Sep 19, 2024 | Sep 20, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Sep 19, 2024 | Sep 20, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALEGRANT Gift | 22,500 | — | — | 131,372 | Sep 6, 2024 | Sep 10, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Gift | 22,500 | — | — | 22,500 | Sep 6, 2024 | Sep 10, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $45.19 | $225.9K | 14,830 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 13,323 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Aug 19, 2024 | Aug 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $45.01 | $225.1K | 14,830 | Jul 19, 2024 | Jul 23, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Jul 19, 2024 | Jul 23, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 18,323 | Jul 19, 2024 | Jul 23, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $37.59 | $188.0K | 14,830 | Jun 20, 2024 | May 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Jun 20, 2024 | May 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 23,323 | Jun 20, 2024 | May 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 13,489 | — | — | 13,489 | Jun 13, 2024 | Jun 14, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 60,000 | $40.08 | $2.40M | 153,872 | Jun 13, 2024 | Jun 14, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 40,000 | $35.07 | $1.40M | 213,872 | Jun 12, 2024 | Jun 14, 2024 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 7,639 | — | — | 7,639 | Jun 5, 2024 | Jun 7, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 28,323 | May 20, 2024 | May 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | May 20, 2024 | May 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $29.90 | $149.5K | 14,830 | May 20, 2024 | May 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 33,323 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $22.82 | $114.1K | 14,830 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Apr 19, 2024 | Apr 22, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 20,000 | $27.11 | $542.2K | 253,872 | Apr 3, 2024 | Apr 3, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 5,000 | — | — | 38,323 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 5,000 | $23.97 | $119.8K | 14,830 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 5,000 | $1.24 | $6.2K | 19,830 | Mar 19, 2024 | Mar 21, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 2,641 | $22.00 | $58.1K | 14,830 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 25,000 | $22.04 | $550.9K | 17,471 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 25,000 | $1.24 | $31.0K | 42,471 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 25,000 | — | — | 43,323 | Mar 12, 2024 | Mar 12, 2024 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 1,859 | $10.13 | $18.8K | 17,471 | Jan 22, 2024 | Jan 23, 2024 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 19,441 | — | — | 19,441 | Jun 13, 2023 | Jun 15, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 100 | — | — | 68,323 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE | 100 | $22.01 | $2.2K | 19,330 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE | 100 | $1.24 | $124 | 19,430 | Mar 15, 2023 | Mar 17, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 9,477 | $23.62 | $223.9K | 19,853 | Feb 14, 2023 | Feb 15, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 10,000 | — | — | 68,423 | Feb 14, 2023 | Feb 15, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 10,000 | $1.24 | $12.4K | 29,330 | Feb 14, 2023 | Feb 15, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 523 | $24.24 | $12.7K | 19,330 | Feb 14, 2023 | Feb 15, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 144,000 | — | — | 144,000 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 18,000 | — | — | 19,330 | Jan 20, 2023 | Jan 24, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 10,000 | $22.00 | $220.0K | 1,330 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 10,000 | — | — | 78,423 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 10,000 | $1.24 | $12.4K | 11,330 | Jan 12, 2023 | Jan 17, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 40,000 | $22.01 | $880.6K | 1,330 | Dec 29, 2022 | Jan 3, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 40,000 | — | — | 88,423 | Dec 29, 2022 | Jan 3, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 40,000 | $1.24 | $49.6K | 41,330 | Dec 29, 2022 | Jan 3, 2023 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 3,499 | $1.24 | $4.3K | 4,829 | Aug 16, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 3,499 | — | — | 128,423 | Aug 16, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 3,499 | $22.08 | $77.3K | 1,330 | Aug 16, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 27,740 | — | — | 0 | Aug 15, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 34,758 | $1.24 | $43.1K | 63,828 | Aug 15, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 62,498 | $22.12 | $1.38M | 1,330 | Aug 15, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 27,740 | $0.53 | $14.7K | 29,070 | Aug 15, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 34,758 | — | — | 131,922 | Aug 15, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 14,003 | $22.00 | $308.1K | 1,330 | Aug 12, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 14,003 | — | — | 27,740 | Aug 12, 2022 | Aug 31, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 14,003 | $0.53 | $7.4K | 15,333 | Aug 12, 2022 | Aug 31, 2022 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,000 | — | — | 21,000 | Jun 7, 2022 | Jun 8, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 115,500 | — | — | 115,500 | Jan 21, 2022 | Mar 15, 2022 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 25,000 | $27.89 | $697.2K | 1,330 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 24,396 | — | — | 166,770 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 604 | $0.53 | $320 | 26,330 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 24,396 | $1.24 | $30.3K | 25,726 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 604 | — | — | 41,743 | Nov 18, 2021 | Nov 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 17,017 | — | — | 191,166 | Jun 25, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 3,083 | — | — | 42,347 | Jun 25, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 2,647 | $29.14 | $77.1K | 1,330 | Jun 25, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 17,017 | $1.24 | $21.1K | 18,347 | Jun 25, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 17,453 | $27.97 | $488.2K | 3,977 | Jun 25, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 3,083 | $0.53 | $1.6K | 21,430 | Jun 25, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 100 | $1.24 | $124 | 1,430 | Jun 24, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 100 | $27.76 | $2.8K | 1,330 | Jun 24, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 100 | — | — | 208,183 | Jun 24, 2021 | Jun 28, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 200 | — | — | 208,283 | Jun 17, 2021 | Jun 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 200 | $1.24 | $248 | 1,530 | Jun 17, 2021 | Jun 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 200 | $27.75 | $5.5K | 1,330 | Jun 17, 2021 | Jun 22, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 23,019 | $26.02 | $599.1K | 0 | Jun 15, 2021 | Jun 16, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 14,003 | $25.92 | $362.9K | 23,019 | Jun 14, 2021 | Jun 16, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,650 | — | — | 11,650 | Jun 8, 2021 | Jun 25, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 1,975 | — | — | 45,430 | Mar 16, 2021 | Mar 18, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 2,625 | $1.24 | $3.3K | 2,625 | Mar 16, 2021 | Mar 18, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 2,625 | — | — | 208,483 | Mar 16, 2021 | Mar 18, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 4,600 | $27.87 | $128.2K | 0 | Mar 16, 2021 | Mar 18, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 1,975 | $0.53 | $1.0K | 4,600 | Mar 16, 2021 | Mar 18, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Gift | 37,022 | — | — | 37,022 | Mar 5, 2021 | Mar 18, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALEGRANT Gift | 37,022 | — | — | 273,872 | Mar 5, 2021 | Mar 18, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 1,842 | $0.40 | $737 | 4,618 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 1,842 | — | — | 0 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 2,776 | $0.40 | $1.1K | 2,776 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 2,776 | — | — | 0 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 7,882 | — | — | 8,764 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 4,957 | $61.14 | $303.1K | 0 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | SALE | 7,543 | $60.55 | $456.8K | 4,957 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASE | 7,882 | $0.60 | $4.7K | 12,500 | Mar 1, 2021 | Mar 3, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 120,000 | — | — | 120,000 | Feb 2, 2021 | Feb 4, 2021 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | PURCHASE Chief Scientific Officer | 16,751 | — | — | 310,894 | Jun 16, 2020 | Jun 16, 2020 ↗ | View → |
| RNA ATRIUM THERAPEUTICS, INC. | SALE Chief Scientific Officer | 35,337 | — | — | 0 | Jun 16, 2020 | Jun 16, 2020 ↗ | View → |
| STOK STOKE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 14,777 | — | — | 14,777 | Jun 3, 2020 | Jun 5, 2020 ↗ | View → |